"Performance" GRANDPHARMA's annual net profit is 1.241 billion yuan, a decrease of 49.7%, with a final dividend of 16.9 cents
GRANDPHARMA (00512.HK) announced its performance for the fiscal year 2025, with revenue of 12.283 billion yuan, an increase of 5.5% year-on-year; gross profit of 6.78 billion yuan, a slight increase of 0.6%. It recorded a net profit of 1.241 billion yuan, a decline of 49.7%, with earnings per share of 35.44 cents. The final dividend is 16.9 Hong Kong cents, compared to 26 Hong Kong cents in the same period last year
Source: AASTOCKS The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments